TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.
about
TRIM36, a novel androgen-responsive gene, enhances anti-androgen efficacy against prostate cancer by inhibiting MAPK/ERK signaling pathways.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@en
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@nl
type
label
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@en
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@nl
prefLabel
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@en
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@nl
P2093
P2860
P1476
TRIM36, a novel androgen-respo ...... g MAPK/ERK signaling pathways.
@en
P2093
Bianjiang Liu
Chao Liang
Gong Cheng
Meilin Bao
Ninghong Song
Pengfei Shao
P2860
P356
10.1038/S41419-017-0197-Y
P577
2018-02-05T00:00:00Z